Why Is Hoth Therapeutics Stock Flying Higher On Tuesday? Hoth Therapeutics' HT-001 shows promising interim Phase 2a trial results, improving skin toxicities in cancer patients without treatment-related adverse effects.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!
Why Is Hoth Therapeutics (HOTH) Stock Moving Today? Hoth Therapeutics stock is slipping on Wednesday even as investors in HOTH learn of a new partnership to assist its Alzheimer's treatment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
HOTH Stock Earnings: Hoth Therapeutics Beats EPS for Q4 2023 HOTH stock results show that Hoth Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday It's time to start the day with a breakdown of the biggest pre-market stock movers worth checking out on Tuesday morning!
HOTH Stock Earnings: Hoth Therapeutics Misses EPS for Q1 2024 HOTH stock results show that Hoth Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Peraso Inc. (
NASDAQ: PRSO ) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.
Why Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday? Hoth Therapeutics reveals preclinical findings on HT-ALZ, a potential Alzheimer's therapeutic targeting the Substance P/Neurokinin 1 Receptor pathway. HT-ALZ exhibits significant reductions in soluble Aβ levels, alleviates anxiety, and enhances cognitive function in preclinical models.
